You are here

Article Text

Article menu
Download PDFPDF
Editorial
Gilbert’s syndrome, circulating bilirubin and lung cancer: a genetic advantage?

https://doi.org/10.1136/thoraxjnl-2020-215642

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @HFreisling

    • Contributors HF conceived and wrote the manuscript. NSK, VV and KHW contributed to the final draft with intellectual importance.

    • Funding The authors declare receiving funding from the French National Cancer Institute (INCa, grant nr. 2016–043), the Austrian Science Fund (FWF, grant nr. P 29608) and the European Commission, BBMRI-LPC (FP7, grant nr. 313010).

    • Disclaimer Where authors are identified as personnel of the International Agency for Research on Cancer/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/WHO.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; externally peer reviewed.

    Linked Articles